| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.974 | 0.002 | 0.974 | Dopamine D2 agonist | 0.864 0.002 DBMET03128 0.846 0.002 DBMET03129 0.861 0.002 DBMET03130 0.696 0.003 DBMET03131 0.737 0.003 DBMET03132 0.86 0.002 DBMET03133 | ||
| 0.923 | 0.002 | 0.926 | Dopamine D1 antagonist | 0.899 0.002 DBMET03128 0.926 0.002 DBMET03129 0.517 0.003 DBMET03130 0.073 0.037 DBMET03131 0.105 0.023 DBMET03132 0.71 0.002 DBMET03133 | DBMET03129 | |
| 0.907 | 0.002 | 0.907 | Dopamine agonist | 0.833 0.003 DBMET03128 0.82 0.003 DBMET03129 0.812 0.003 DBMET03130 0.585 0.004 DBMET03131 0.62 0.004 DBMET03132 0.857 0.003 DBMET03133 | ||
| 0.905 | 0.001 | 0.905 | Tyrosine 3 hydroxylase inhibitor | 0.843 0.002 DBMET03128 0.838 0.002 DBMET03129 0.772 0.002 DBMET03130 0.335 0.02 DBMET03131 0.331 0.021 DBMET03132 0.89 0.001 DBMET03133 | ||
| 0.857 | 0.002 | 0.857 | Dopamine D5 antagonist | 0.751 0.002 DBMET03128 0.723 0.002 DBMET03129 0.743 0.002 DBMET03130 0.257 0.004 DBMET03131 0.227 0.005 DBMET03132 0.754 0.002 DBMET03133 | ||
| 0.786 | 0.004 | 0.816 | 5 Hydroxytryptamine release stimulant | 0.816 0.003 DBMET03128 0.73 0.005 DBMET03129 0.727 0.005 DBMET03130 0.733 0.005 DBMET03131 0.656 0.01 DBMET03132 0.745 0.005 DBMET03133 | DBMET03128 | |
| 0.774 | 0.003 | 0.786 | 5 Hydroxytryptamine 7 antagonist | 0.749 0.003 DBMET03128 0.757 0.003 DBMET03129 0.786 0.003 DBMET03130 0.229 0.009 DBMET03131 0.162 0.017 DBMET03132 0.596 0.004 DBMET03133 | DBMET03130 | |
| 0.738 | 0.004 | 0.752 | Dopamine antagonist | 0.73 0.004 DBMET03128 0.752 0.004 DBMET03129 0.438 0.007 DBMET03130 0.465 0.006 DBMET03133 | DBMET03129 | |
| 0.701 | 0.004 | 0.722 | Dopamine D2 antagonist | 0.698 0.004 DBMET03128 0.722 0.004 DBMET03129 0.407 0.007 DBMET03130 0.432 0.006 DBMET03133 | DBMET03129 | |
| 0.662 | 0.003 | 0.675 | Alpha 2a adrenoreceptor antagonist | 0.675 0.003 DBMET03128 0.63 0.003 DBMET03129 0.329 0.006 DBMET03130 0.513 0.004 DBMET03133 | DBMET03128 | |
| 0.654 | 0.009 | 0.774 | Spasmolytic | 0.643 0.009 DBMET03128 0.667 0.008 DBMET03129 0.554 0.017 DBMET03130 0.774 0.004 DBMET03131 0.747 0.005 DBMET03132 0.477 0.026 DBMET03133 | DBMET03131 | |
| 0.606 | 0.007 | 0.636 | Hypoxia-inducible factor 1 alpha inhibitor | 0.63 0.006 DBMET03128 0.636 0.006 DBMET03129 0.518 0.013 DBMET03130 0.607 0.007 DBMET03131 0.579 0.009 DBMET03132 0.426 0.024 DBMET03133 | DBMET03129 | |
| 0.567 | 0.004 | 0.59 | Alpha 2 adrenoreceptor antagonist | 0.59 0.004 DBMET03128 0.563 0.004 DBMET03129 0.298 0.008 DBMET03130 0.425 0.005 DBMET03133 | DBMET03128 | |
| 0.58 | 0.022 | 0.668 | Aldehyde oxidase inhibitor | 0.571 0.023 DBMET03128 0.668 0.011 DBMET03129 0.362 0.053 DBMET03130 0.391 0.048 DBMET03133 | DBMET03129 | |
| 0.561 | 0.005 | 0.573 | Sigma receptor agonist | 0.565 0.005 DBMET03128 0.552 0.005 DBMET03129 0.573 0.005 DBMET03130 0.275 0.044 DBMET03131 0.275 0.044 DBMET03132 0.208 0.059 DBMET03133 | DBMET03130 | |
| 0.559 | 0.004 | 0.609 | Alpha 2b adrenoreceptor antagonist | 0.609 0.003 DBMET03128 0.588 0.004 DBMET03129 0.357 0.006 DBMET03130 0.388 0.005 DBMET03133 | DBMET03128 | |
| 0.533 | 0.005 | 0.722 | Cyclic AMP phosphodiesterase inhibitor | 0.552 0.005 DBMET03128 0.483 0.008 DBMET03129 0.401 0.016 DBMET03130 0.722 0.003 DBMET03131 0.673 0.004 DBMET03132 0.422 0.014 DBMET03133 | DBMET03131 | |
| 0.522 | 0.001 | 0.522 | Prolactin inhibitor | 0.445 0.002 DBMET03128 0.432 0.002 DBMET03129 0.38 0.002 DBMET03130 0.165 0.017 DBMET03131 0.157 0.019 DBMET03132 0.441 0.002 DBMET03133 | ||
| 0.555 | 0.037 | 0.859 | Transcription factor NF kappa B inhibitor | 0.567 0.035 DBMET03128 0.575 0.034 DBMET03129 0.419 0.059 DBMET03130 0.859 0.009 DBMET03131 0.805 0.012 DBMET03132 0.448 0.053 DBMET03133 | DBMET03131 | |
| 0.517 | 0.004 | 0.52 | 5 Hydroxytryptamine 1F antagonist | 0.405 0.005 DBMET03128 0.402 0.005 DBMET03129 0.52 0.004 DBMET03130 0.06 0.059 DBMET03131 0.106 0.029 DBMET03133 | DBMET03130 | |
| 0.516 | 0.025 | 0.634 | Vasodilator, peripheral | 0.545 0.021 DBMET03128 0.634 0.012 DBMET03129 0.429 0.046 DBMET03130 0.521 0.024 DBMET03131 0.533 0.023 DBMET03132 0.334 0.081 DBMET03133 | DBMET03129 | |
| 0.494 | 0.003 | 0.494 | 5 Hydroxytryptamine 5A antagonist | 0.468 0.003 DBMET03128 0.482 0.003 DBMET03129 0.286 0.004 DBMET03130 0.144 0.008 DBMET03133 | ||
| 0.485 | 0.002 | 0.485 | Dopamine D1 agonist | 0.308 0.002 DBMET03128 0.298 0.002 DBMET03129 0.238 0.002 DBMET03130 0.207 0.003 DBMET03131 0.261 0.002 DBMET03132 0.425 0.002 DBMET03133 | ||
| 0.521 | 0.043 | 0.521 | Analgesic | 0.395 0.087 DBMET03128 0.43 0.072 DBMET03129 0.514 0.045 DBMET03130 0.24 0.192 DBMET03131 0.265 0.17 DBMET03132 0.447 0.066 DBMET03133 | ||
| 0.484 | 0.013 | 0.517 | Vasodilator | 0.434 0.018 DBMET03128 0.425 0.019 DBMET03129 0.426 0.019 DBMET03130 0.517 0.011 DBMET03131 0.483 0.013 DBMET03132 0.417 0.02 DBMET03133 | DBMET03131 | |
| 0.523 | 0.052 | 0.62 | Caspase 9 stimulant | 0.603 0.036 DBMET03128 0.62 0.033 DBMET03129 0.529 0.05 DBMET03130 0.495 0.062 DBMET03131 0.49 0.064 DBMET03132 0.508 0.057 DBMET03133 | DBMET03129 | |
| 0.499 | 0.04 | 0.499 | 15-Lipoxygenase inhibitor | 0.462 0.05 DBMET03128 0.471 0.047 DBMET03129 0.407 0.072 DBMET03130 0.49 0.043 DBMET03133 | ||
| 0.461 | 0.004 | 0.516 | Alpha 2c adrenoreceptor antagonist | 0.516 0.004 DBMET03128 0.485 0.004 DBMET03129 0.33 0.005 DBMET03130 0.123 0.047 DBMET03131 0.095 0.07 DBMET03132 0.281 0.007 DBMET03133 | DBMET03128 | |
| 0.485 | 0.034 | 0.655 | Histamine release inhibitor | 0.437 0.056 DBMET03128 0.504 0.027 DBMET03129 0.428 0.061 DBMET03130 0.652 0.006 DBMET03131 0.655 0.006 DBMET03132 0.329 0.109 DBMET03133 | DBMET03132 | |
| 0.459 | 0.009 | 0.514 | Calcium channel activator | 0.514 0.004 DBMET03128 0.454 0.01 DBMET03129 0.432 0.015 DBMET03130 0.263 0.132 DBMET03131 0.208 0.201 DBMET03132 0.436 0.014 DBMET03133 | DBMET03128 | |
| 0.512 | 0.071 | 0.627 | Apoptosis agonist | 0.505 0.073 DBMET03128 0.516 0.069 DBMET03129 0.505 0.073 DBMET03130 0.625 0.044 DBMET03131 0.627 0.044 DBMET03132 0.397 0.115 DBMET03133 | DBMET03132 | |
| 0.444 | 0.008 | 0.538 | Alpha adrenoreceptor antagonist | 0.538 0.005 DBMET03128 0.5 0.006 DBMET03129 0.242 0.021 DBMET03130 0.276 0.018 DBMET03133 | DBMET03128 | |
| 0.436 | 0.003 | 0.458 | 5 Hydroxytryptamine 5 antagonist | 0.444 0.003 DBMET03128 0.458 0.003 DBMET03129 0.265 0.004 DBMET03130 0.133 0.009 DBMET03133 | DBMET03129 | |
| 0.435 | 0.005 | 0.435 | Acetylcholine M1 receptor antagonist | 0.369 0.007 DBMET03128 0.369 0.007 DBMET03129 0.353 0.008 DBMET03130 0.169 0.059 DBMET03131 0.165 0.062 DBMET03132 0.291 0.016 DBMET03133 | ||
| 0.427 | 0.007 | 0.51 | 5 Hydroxytryptamine 2B antagonist | 0.51 0.005 DBMET03128 0.477 0.005 DBMET03129 0.417 0.008 DBMET03130 0.203 0.026 DBMET03133 | DBMET03128 | |
| 0.423 | 0.005 | 0.423 | Dopamine D4 antagonist | 0.418 0.005 DBMET03128 0.395 0.005 DBMET03129 0.25 0.009 DBMET03130 0.211 0.011 DBMET03133 | ||
| 0.434 | 0.018 | 0.483 | Psychostimulant | 0.412 0.02 DBMET03128 0.426 0.019 DBMET03129 0.39 0.024 DBMET03130 0.438 0.017 DBMET03131 0.483 0.012 DBMET03132 0.361 0.029 DBMET03133 | DBMET03132 | |
| 0.413 | 0.004 | 0.431 | Dopamine D3 antagonist | 0.42 0.004 DBMET03128 0.431 0.004 DBMET03129 0.239 0.008 DBMET03130 0.221 0.009 DBMET03133 | DBMET03129 | |
| 0.4 | 0.004 | 0.4 | Opioid kappa receptor antagonist | 0.359 0.004 DBMET03128 0.353 0.005 DBMET03129 0.369 0.004 DBMET03130 0.171 0.014 DBMET03131 0.151 0.017 DBMET03132 0.239 0.007 DBMET03133 | ||
| 0.404 | 0.01 | 0.467 | 5 Hydroxytryptamine 2 antagonist | 0.458 0.007 DBMET03128 0.467 0.007 DBMET03129 0.417 0.009 DBMET03130 0.171 0.038 DBMET03133 | DBMET03129 | |
| 0.401 | 0.029 | 0.567 | Free radical scavenger | 0.331 0.044 DBMET03128 0.37 0.035 DBMET03129 0.243 0.071 DBMET03130 0.567 0.01 DBMET03131 0.56 0.011 DBMET03132 0.398 0.029 DBMET03133 | DBMET03131 | |
| 0.38 | 0.012 | 0.474 | 5 Hydroxytryptamine antagonist | 0.458 0.009 DBMET03128 0.474 0.008 DBMET03129 0.441 0.009 DBMET03130 0.218 0.03 DBMET03133 | DBMET03129 | |
| 0.385 | 0.018 | 0.43 | Anesthetic general | 0.396 0.017 DBMET03128 0.381 0.019 DBMET03129 0.308 0.031 DBMET03130 0.43 0.013 DBMET03131 0.396 0.017 DBMET03132 0.232 0.058 DBMET03133 | DBMET03131 | |
| 0.373 | 0.006 | 0.373 | M18 aspartyl aminopeptidase inhibitor | 0.272 0.017 DBMET03128 0.297 0.013 DBMET03129 0.214 0.03 DBMET03130 0.11 0.08 DBMET03131 0.117 0.074 DBMET03132 0.317 0.01 DBMET03133 | ||
| 0.369 | 0.007 | 0.371 | 5 Hydroxytryptamine 1E antagonist | 0.364 0.008 DBMET03128 0.371 0.007 DBMET03129 0.359 0.008 DBMET03130 0.261 0.063 DBMET03133 | DBMET03129 | |
| 0.365 | 0.007 | 0.501 | 5 Hydroxytryptamine 1A antagonist | 0.465 0.005 DBMET03128 0.501 0.004 DBMET03129 0.326 0.008 DBMET03130 0.187 0.016 DBMET03133 | DBMET03129 | |
| 0.367 | 0.009 | 0.367 | Cholinergic antagonist | 0.309 0.013 DBMET03128 0.322 0.012 DBMET03129 0.286 0.016 DBMET03130 0.114 0.08 DBMET03131 0.104 0.09 DBMET03132 0.254 0.02 DBMET03133 | ||
| 0.363 | 0.009 | 0.363 | Acetylcholine antagonist | 0.304 0.013 DBMET03128 0.318 0.012 DBMET03129 0.28 0.016 DBMET03130 0.1 0.092 DBMET03131 0.252 0.02 DBMET03133 | ||
| 0.39 | 0.04 | 0.406 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.406 0.037 DBMET03128 0.324 0.058 DBMET03129 0.353 0.049 DBMET03130 0.186 0.109 DBMET03133 | DBMET03128 | |
| 0.356 | 0.008 | 0.481 | 5 Hydroxytryptamine 1 antagonist | 0.453 0.005 DBMET03128 0.481 0.005 DBMET03129 0.361 0.008 DBMET03130 0.152 0.023 DBMET03133 | DBMET03129 | |
| 0.351 | 0.01 | 0.351 | Antiadrenergic | 0.325 0.012 DBMET03128 0.297 0.014 DBMET03129 0.21 0.022 DBMET03130 0.271 0.016 DBMET03133 | ||
| 0.361 | 0.023 | 0.39 | 5 Hydroxytryptamine uptake stimulant | 0.328 0.033 DBMET03128 0.344 0.027 DBMET03129 0.297 0.046 DBMET03130 0.39 0.016 DBMET03133 | DBMET03133 | |
| 0.334 | 0.009 | 0.405 | 5 Hydroxytryptamine 2A antagonist | 0.385 0.007 DBMET03128 0.405 0.007 DBMET03129 0.373 0.008 DBMET03130 0.125 0.036 DBMET03133 | DBMET03129 | |
| 0.366 | 0.042 | 0.61 | Antioxidant | 0.303 0.06 DBMET03128 0.326 0.053 DBMET03129 0.237 0.091 DBMET03130 0.61 0.011 DBMET03131 0.599 0.011 DBMET03132 0.358 0.044 DBMET03133 | DBMET03131 | |
| 0.329 | 0.005 | 0.329 | Opioid antagonist | 0.247 0.008 DBMET03128 0.238 0.009 DBMET03129 0.258 0.007 DBMET03130 0.157 0.024 DBMET03131 0.145 0.027 DBMET03132 0.187 0.017 DBMET03133 | ||
| 0.328 | 0.011 | 0.328 | Adrenaline antagonist | 0.304 0.013 DBMET03128 0.276 0.015 DBMET03129 0.193 0.025 DBMET03130 0.252 0.017 DBMET03133 | ||
| 0.305 | 0.005 | 0.32 | Sigma receptor antagonist | 0.239 0.008 DBMET03128 0.269 0.007 DBMET03129 0.32 0.005 DBMET03130 0.121 0.014 DBMET03133 | DBMET03130 | |
| 0.337 | 0.038 | 0.337 | Pyruvate kinase inhibitor | 0.306 0.046 DBMET03128 0.263 0.058 DBMET03129 0.181 0.093 DBMET03130 0.335 0.039 DBMET03133 | ||
| 0.3 | 0.005 | 0.3 | Opioid mu receptor antagonist | 0.217 0.007 DBMET03128 0.208 0.008 DBMET03129 0.227 0.007 DBMET03130 0.135 0.021 DBMET03131 0.124 0.024 DBMET03132 0.162 0.015 DBMET03133 | ||
| 0.299 | 0.013 | 0.299 | Anesthetic local | 0.287 0.014 DBMET03128 0.246 0.021 DBMET03129 0.22 0.027 DBMET03130 0.157 0.046 DBMET03133 | ||
| 0.292 | 0.012 | 0.404 | Alpha 1 adrenoreceptor antagonist | 0.404 0.006 DBMET03128 0.352 0.008 DBMET03129 0.174 0.025 DBMET03130 0.15 0.029 DBMET03133 | DBMET03128 | |
| 0.281 | 0.005 | 0.346 | Alpha adrenoreceptor agonist | 0.25 0.005 DBMET03128 0.223 0.007 DBMET03129 0.125 0.021 DBMET03130 0.346 0.004 DBMET03133 | DBMET03133 | |
| 0.294 | 0.019 | 0.403 | NOS3 expression enhancer | 0.192 0.044 DBMET03128 0.24 0.029 DBMET03129 0.287 0.02 DBMET03130 0.363 0.01 DBMET03131 0.403 0.008 DBMET03132 0.178 0.051 DBMET03133 | DBMET03132 | |
| 0.279 | 0.008 | 0.283 | Acetylcholine nicotinic antagonist | 0.247 0.009 DBMET03128 0.283 0.008 DBMET03129 0.28 0.008 DBMET03130 0.228 0.01 DBMET03133 | DBMET03129 | |
| 0.269 | 0.006 | 0.269 | Analgesic, opioid | 0.194 0.01 DBMET03128 0.199 0.009 DBMET03129 0.213 0.009 DBMET03130 0.118 0.023 DBMET03131 0.114 0.025 DBMET03132 0.146 0.015 DBMET03133 | ||
| 0.273 | 0.01 | 0.69 | Expectorant | 0.318 0.008 DBMET03128 0.26 0.012 DBMET03129 0.144 0.038 DBMET03130 0.69 0.002 DBMET03131 0.62 0.003 DBMET03132 0.201 0.02 DBMET03133 | DBMET03131 | |
| 0.333 | 0.071 | 0.748 | Antithrombotic | 0.301 0.087 DBMET03128 0.306 0.084 DBMET03129 0.326 0.074 DBMET03130 0.748 0.006 DBMET03131 0.717 0.007 DBMET03132 0.301 0.087 DBMET03133 | DBMET03131 | |
| 0.269 | 0.012 | 0.269 | Acetylcholine muscarinic antagonist | 0.228 0.018 DBMET03128 0.223 0.019 DBMET03129 0.202 0.024 DBMET03130 0.098 0.093 DBMET03131 0.146 0.046 DBMET03133 | ||
| 0.258 | 0.005 | 0.258 | Opioid delta receptor antagonist | 0.208 0.01 DBMET03128 0.201 0.011 DBMET03129 0.204 0.01 DBMET03130 0.102 0.03 DBMET03131 0.091 0.032 DBMET03132 0.165 0.017 DBMET03133 | ||
| 0.254 | 0.004 | 0.291 | Alpha 2 adrenoreceptor agonist | 0.193 0.005 DBMET03128 0.186 0.005 DBMET03129 0.129 0.009 DBMET03130 0.291 0.004 DBMET03133 | DBMET03133 | |
| 0.273 | 0.023 | 0.313 | Cholinergic | 0.278 0.022 DBMET03128 0.313 0.017 DBMET03129 0.296 0.019 DBMET03130 0.225 0.036 DBMET03133 | DBMET03129 | |
| 0.254 | 0.004 | 0.255 | Antineoplastic alkaloid | 0.245 0.005 DBMET03128 0.255 0.004 DBMET03129 0.244 0.005 DBMET03130 0.188 0.017 DBMET03131 0.198 0.014 DBMET03132 0.236 0.006 DBMET03133 | DBMET03129 | |
| 0.275 | 0.026 | 0.299 | Neurotrophic factor enhancer | 0.243 0.042 DBMET03128 0.221 0.058 DBMET03129 0.175 0.104 DBMET03130 0.299 0.018 DBMET03131 0.267 0.03 DBMET03132 0.266 0.03 DBMET03133 | DBMET03131 | |
| 0.257 | 0.014 | 0.257 | Cystathionine beta-synthase inhibitor | 0.207 0.023 DBMET03128 0.206 0.023 DBMET03129 0.167 0.034 DBMET03130 0.204 0.023 DBMET03131 0.203 0.024 DBMET03132 0.198 0.025 DBMET03133 | ||
| 0.24 | 0.004 | 0.24 | Opioid mu receptor agonist | 0.182 0.005 DBMET03128 0.173 0.005 DBMET03129 0.201 0.005 DBMET03130 0.088 0.016 DBMET03131 0.083 0.017 DBMET03132 0.122 0.009 DBMET03133 | ||
| 0.234 | 0.005 | 0.234 | Opioid agonist | 0.164 0.006 DBMET03128 0.155 0.007 DBMET03129 0.183 0.005 DBMET03130 0.075 0.021 DBMET03131 0.07 0.023 DBMET03132 0.128 0.009 DBMET03133 | ||
| 0.235 | 0.007 | 0.235 | Neuronal nicotinic receptor antagonist | 0.188 0.009 DBMET03128 0.223 0.007 DBMET03129 0.205 0.008 DBMET03130 0.188 0.009 DBMET03133 | ||
| 0.299 | 0.08 | 0.397 | 12-Lipoxygenase inhibitor | 0.299 0.08 DBMET03128 0.277 0.093 DBMET03129 0.221 0.129 DBMET03130 0.397 0.04 DBMET03133 | DBMET03133 | |
| 0.277 | 0.06 | 0.462 | Superoxide dismutase inhibitor | 0.29 0.054 DBMET03128 0.3 0.05 DBMET03129 0.204 0.113 DBMET03130 0.462 0.017 DBMET03133 | DBMET03133 | |
| 0.228 | 0.014 | 0.324 | Alpha 1a adrenoreceptor antagonist | 0.324 0.008 DBMET03128 0.283 0.01 DBMET03129 0.131 0.027 DBMET03130 0.103 0.035 DBMET03133 | DBMET03128 | |
| 0.223 | 0.015 | 0.288 | 5 Hydroxytryptamine 2C antagonist | 0.288 0.009 DBMET03128 0.206 0.016 DBMET03129 0.22 0.015 DBMET03130 0.105 0.042 DBMET03133 | DBMET03128 | |
| 0.269 | 0.063 | 0.362 | Antiamyloidogenic | 0.295 0.053 DBMET03128 0.337 0.042 DBMET03129 0.181 0.113 DBMET03130 0.362 0.036 DBMET03131 0.347 0.039 DBMET03132 0.22 0.086 DBMET03133 | DBMET03131 | |
| 0.21 | 0.006 | 0.24 | Alpha 1 adrenoreceptor agonist | 0.24 0.005 DBMET03128 0.18 0.007 DBMET03129 0.105 0.015 DBMET03130 0.126 0.012 DBMET03133 | DBMET03128 | |
| 0.311 | 0.109 | 0.327 | GABA C receptor rho-3 antagonist | 0.327 0.099 DBMET03130 0.301 0.115 DBMET03133 | DBMET03130 | |
| 0.233 | 0.031 | 0.329 | Lipid peroxidase inhibitor | 0.191 0.045 DBMET03128 0.23 0.031 DBMET03129 0.152 0.067 DBMET03130 0.324 0.016 DBMET03131 0.329 0.015 DBMET03132 0.234 0.03 DBMET03133 | DBMET03132 | |
| 0.301 | 0.101 | 0.301 | Prostaglandin dehydrogenase inhibitor | 0.262 0.121 DBMET03128 0.274 0.115 DBMET03129 0.28 0.111 DBMET03130 | ||
| 0.24 | 0.046 | 0.46 | Hepatoprotectant | 0.222 0.053 DBMET03128 0.241 0.046 DBMET03129 0.171 0.088 DBMET03130 0.46 0.009 DBMET03131 0.439 0.01 DBMET03132 0.194 0.068 DBMET03133 | DBMET03131 | |
| 0.197 | 0.005 | 0.197 | Opioid kappa receptor agonist | 0.167 0.005 DBMET03128 0.148 0.006 DBMET03129 0.17 0.005 DBMET03130 0.09 0.011 DBMET03131 0.082 0.012 DBMET03132 0.116 0.008 DBMET03133 | ||
| 0.238 | 0.045 | 0.292 | P-glycoprotein inhibitor | 0.292 0.031 DBMET03128 0.276 0.034 DBMET03129 0.237 0.046 DBMET03130 0.223 0.052 DBMET03131 0.195 0.067 DBMET03132 0.157 0.106 DBMET03133 | DBMET03128 | |
| 0.264 | 0.073 | 0.318 | DNA damaging | 0.284 0.064 DBMET03128 0.255 0.077 DBMET03129 0.318 0.051 DBMET03130 0.272 0.069 DBMET03131 0.27 0.07 DBMET03132 0.278 0.067 DBMET03133 | DBMET03130 | |
| 0.357 | 0.167 | 0.735 | Antiinflammatory | 0.264 0.251 DBMET03128 0.282 0.232 DBMET03129 0.732 0.025 DBMET03131 0.735 0.025 DBMET03132 0.383 0.149 DBMET03133 | DBMET03132 | |
| 0.197 | 0.012 | 0.197 | HIV-1 integrase (Overall Integration) inhibitor | 0.119 0.04 DBMET03128 0.119 0.04 DBMET03129 0.091 0.064 DBMET03130 0.191 0.013 DBMET03133 | ||
| 0.211 | 0.03 | 0.26 | Acetylcholinesterase inhibitor | 0.232 0.025 DBMET03128 0.26 0.019 DBMET03129 0.221 0.027 DBMET03130 0.135 0.065 DBMET03133 | DBMET03129 | |
| 0.298 | 0.116 | 0.514 | Immunosuppressant | 0.276 0.131 DBMET03128 0.288 0.123 DBMET03129 0.364 0.079 DBMET03130 0.494 0.035 DBMET03131 0.514 0.029 DBMET03132 0.356 0.083 DBMET03133 | DBMET03132 | |
| 0.202 | 0.026 | 0.399 | Alkylator | 0.215 0.022 DBMET03128 0.181 0.033 DBMET03129 0.213 0.023 DBMET03130 0.399 0.008 DBMET03131 0.344 0.01 DBMET03132 0.143 0.05 DBMET03133 | DBMET03131 | |
| 0.275 | 0.103 | 0.325 | Sodium/bile acid cotransporter inhibitor | 0.297 0.082 DBMET03128 0.325 0.058 DBMET03129 0.218 0.164 DBMET03131 0.218 0.164 DBMET03132 0.27 0.108 DBMET03133 | DBMET03129 | |
| 0.182 | 0.014 | 0.182 | Creatine kinase inhibitor | 0.087 0.076 DBMET03128 0.112 0.047 DBMET03129 0.144 0.027 DBMET03130 0.171 0.017 DBMET03133 | ||
| 0.169 | 0.002 | 0.169 | Prolactin release inhibitor | 0.147 0.002 DBMET03128 0.15 0.002 DBMET03129 0.169 0.002 DBMET03130 0.109 0.004 DBMET03131 0.111 0.004 DBMET03132 0.112 0.004 DBMET03133 | ||
| 0.177 | 0.01 | 0.202 | 5 Hydroxytryptamine 1B antagonist | 0.186 0.009 DBMET03128 0.167 0.011 DBMET03129 0.202 0.008 DBMET03130 0.059 0.053 DBMET03133 | DBMET03130 | |
| 0.202 | 0.036 | 0.37 | Tubulin antagonist | 0.304 0.019 DBMET03128 0.37 0.013 DBMET03129 0.186 0.042 DBMET03130 0.216 0.032 DBMET03133 | DBMET03129 | |
| 0.226 | 0.063 | 0.395 | DNA methylase inhibitor | 0.261 0.042 DBMET03128 0.208 0.074 DBMET03129 0.205 0.076 DBMET03130 0.395 0.011 DBMET03131 0.328 0.021 DBMET03132 0.137 0.129 DBMET03133 | DBMET03131 | |
| 0.176 | 0.015 | 0.493 | AMP-activated protein kinase stimulant | 0.162 0.021 DBMET03128 0.162 0.021 DBMET03129 0.147 0.03 DBMET03130 0.493 0.003 DBMET03131 0.417 0.004 DBMET03132 0.183 0.014 DBMET03133 | DBMET03131 | |
| 0.235 | 0.082 | 0.521 | Tumour necrosis factor alpha release inhibitor | 0.296 0.055 DBMET03128 0.276 0.063 DBMET03129 0.162 0.142 DBMET03130 0.518 0.012 DBMET03131 0.521 0.012 DBMET03132 0.197 0.111 DBMET03133 | DBMET03132 | |
| 0.221 | 0.073 | 0.227 | RNA-directed DNA polymerase inhibitor | 0.194 0.109 DBMET03128 0.206 0.091 DBMET03129 0.215 0.08 DBMET03130 0.179 0.135 DBMET03131 0.175 0.143 DBMET03132 0.227 0.066 DBMET03133 | DBMET03133 | |
| 0.167 | 0.019 | 0.227 | Alpha 1b adrenoreceptor antagonist | 0.227 0.012 DBMET03128 0.193 0.015 DBMET03129 0.093 0.038 DBMET03130 0.087 0.041 DBMET03133 | DBMET03128 | |
| 0.166 | 0.02 | 0.322 | NMDA receptor antagonist | 0.086 0.059 DBMET03128 0.094 0.051 DBMET03129 0.109 0.041 DBMET03130 0.322 0.005 DBMET03133 | DBMET03133 | |
| 0.171 | 0.026 | 0.171 | Nav1.1 sodium channel blocker | 0.158 0.03 DBMET03128 0.146 0.035 DBMET03129 0.158 0.03 DBMET03130 | ||
| 0.287 | 0.145 | 0.655 | Antibacterial | 0.238 0.189 DBMET03129 0.27 0.159 DBMET03130 0.654 0.013 DBMET03131 0.655 0.013 DBMET03132 0.393 0.08 DBMET03133 | DBMET03132 | |
| 0.134 | 0.003 | 0.34 | Dopamine D5 agonist | 0.076 0.007 DBMET03128 0.064 0.01 DBMET03129 0.048 0.019 DBMET03130 0.34 0.001 DBMET03133 | DBMET03133 | |
| 0.172 | 0.042 | 0.203 | Toll-Like receptor antagonist | 0.174 0.041 DBMET03128 0.144 0.06 DBMET03129 0.168 0.044 DBMET03130 0.203 0.03 DBMET03133 | DBMET03133 | |
| 0.143 | 0.013 | 0.191 | 5 Hydroxytryptamine 1D antagonist | 0.166 0.01 DBMET03128 0.144 0.013 DBMET03129 0.191 0.007 DBMET03130 | DBMET03130 | |
| 0.136 | 0.007 | 0.16 | Nicotinic receptor alpha7 subunit antagonist | 0.115 0.01 DBMET03128 0.151 0.006 DBMET03129 0.16 0.005 DBMET03130 0.105 0.011 DBMET03133 | DBMET03130 | |
| 0.145 | 0.016 | 0.145 | Histamine N-methyltransferase inhibitor | 0.108 0.039 DBMET03128 0.103 0.043 DBMET03129 0.135 0.021 DBMET03130 0.081 0.066 DBMET03133 | ||
| 0.208 | 0.079 | 0.35 | Antimitotic | 0.314 0.04 DBMET03128 0.35 0.032 DBMET03129 0.183 0.094 DBMET03130 0.204 0.082 DBMET03133 | DBMET03129 | |
| 0.138 | 0.01 | 0.138 | HIV-1 integrase inhibitor | 0.099 0.025 DBMET03128 0.087 0.033 DBMET03129 0.063 0.06 DBMET03130 0.07 0.048 DBMET03131 0.071 0.048 DBMET03132 0.122 0.014 DBMET03133 | ||
| 0.129 | 0.014 | 0.131 | Nicotinic alpha4beta2 receptor antagonist | 0.114 0.021 DBMET03128 0.113 0.022 DBMET03129 0.131 0.013 DBMET03130 0.124 0.015 DBMET03133 | DBMET03130 | |
| 0.126 | 0.011 | 0.126 | Dopamine D4 agonist | 0.094 0.016 DBMET03128 0.073 0.022 DBMET03129 0.076 0.021 DBMET03130 0.054 0.031 DBMET03133 | ||
| 0.187 | 0.073 | 0.414 | Nitric oxide antagonist | 0.176 0.078 DBMET03128 0.184 0.074 DBMET03129 0.135 0.112 DBMET03130 0.395 0.026 DBMET03131 0.414 0.024 DBMET03132 0.175 0.079 DBMET03133 | DBMET03132 | |
| 0.127 | 0.013 | 0.127 | Dopamine uptake inhibitor | 0.107 0.017 DBMET03128 0.1 0.018 DBMET03129 0.096 0.02 DBMET03130 0.097 0.019 DBMET03133 | ||
| 0.145 | 0.034 | 0.145 | Protein kinase C gamma inhibitor | 0.128 0.046 DBMET03128 0.128 0.046 DBMET03129 0.125 0.048 DBMET03133 | ||
| 0.174 | 0.065 | 0.318 | ATPase inhibitor | 0.172 0.068 DBMET03128 0.181 0.057 DBMET03129 0.135 0.13 DBMET03130 0.287 0.007 DBMET03131 0.318 0.005 DBMET03132 | DBMET03132 | |
| 0.15 | 0.042 | 0.15 | Ca2+-transporting ATPase inhibitor | 0.142 0.067 DBMET03128 0.142 0.067 DBMET03129 0.143 0.062 DBMET03130 0.147 0.052 DBMET03131 0.147 0.052 DBMET03132 0.143 0.063 DBMET03133 | ||
| 0.151 | 0.044 | 0.17 | Adenylate cyclase inhibitor | 0.11 0.075 DBMET03129 0.093 0.09 DBMET03130 0.115 0.072 DBMET03132 0.17 0.034 DBMET03133 | DBMET03133 | |
| 0.136 | 0.032 | 0.141 | Estrogen antagonist | 0.123 0.05 DBMET03128 0.123 0.049 DBMET03129 0.104 0.089 DBMET03131 0.1 0.098 DBMET03132 0.141 0.027 DBMET03133 | DBMET03133 | |
| 0.109 | 0.006 | 0.197 | 5 Hydroxytryptamine 7 agonist | 0.197 0.004 DBMET03128 0.146 0.004 DBMET03129 0.112 0.005 DBMET03130 0.072 0.018 DBMET03133 | DBMET03128 | |
| 0.128 | 0.025 | 0.128 | Estrogen receptor beta antagonist | 0.114 0.04 DBMET03128 0.115 0.039 DBMET03129 0.096 0.073 DBMET03130 0.126 0.026 DBMET03133 | ||
| 0.12 | 0.019 | 0.2 | Alpha 1d adrenoreceptor antagonist | 0.2 0.01 DBMET03128 0.174 0.012 DBMET03129 0.095 0.024 DBMET03130 0.055 0.045 DBMET03133 | DBMET03128 | |
| 0.128 | 0.028 | 0.138 | Protein kinase C zeta inhibitor | 0.113 0.037 DBMET03128 0.114 0.037 DBMET03129 0.138 0.023 DBMET03133 | DBMET03133 | |
| 0.231 | 0.131 | 0.343 | Caspase 3 stimulant | 0.277 0.091 DBMET03128 0.343 0.061 DBMET03129 0.321 0.069 DBMET03130 0.269 0.097 DBMET03131 0.314 0.072 DBMET03132 | DBMET03129 | |
| 0.119 | 0.019 | 0.119 | Estrogen receptor alpha antagonist | 0.091 0.034 DBMET03128 0.095 0.031 DBMET03129 0.076 0.056 DBMET03130 0.108 0.023 DBMET03133 | ||
| 0.108 | 0.008 | 0.161 | 5 Hydroxytryptamine 2 agonist | 0.117 0.007 DBMET03128 0.161 0.005 DBMET03129 0.11 0.008 DBMET03130 0.125 0.006 DBMET03133 | DBMET03129 | |
| 0.119 | 0.019 | 0.186 | CDC25A inhibitor | 0.08 0.043 DBMET03128 0.186 0.008 DBMET03130 0.153 0.012 DBMET03133 | DBMET03130 | |
| 0.102 | 0.007 | 0.118 | 5 Hydroxytryptamine 1B agonist | 0.083 0.011 DBMET03128 0.089 0.009 DBMET03129 0.118 0.005 DBMET03130 0.059 0.028 DBMET03133 | DBMET03130 | |
| 0.116 | 0.021 | 0.168 | HIV-1 integrase (3'-Processing) inhibitor | 0.065 0.043 DBMET03128 0.071 0.038 DBMET03129 0.061 0.046 DBMET03131 0.061 0.046 DBMET03132 0.168 0.012 DBMET03133 | DBMET03133 | |
| 0.129 | 0.035 | 0.174 | Toll-Like receptor 4 antagonist | 0.132 0.033 DBMET03128 0.121 0.042 DBMET03129 0.174 0.011 DBMET03131 0.172 0.012 DBMET03132 0.13 0.035 DBMET03133 | DBMET03131 | |
| 0.101 | 0.007 | 0.102 | Nicotinic alpha3beta2 receptor antagonist | 0.08 0.013 DBMET03128 0.08 0.013 DBMET03129 0.102 0.007 DBMET03130 0.101 0.008 DBMET03133 | DBMET03130 | |
| 0.148 | 0.056 | 0.166 | NADPH oxidase inhibitor | 0.158 0.05 DBMET03128 0.166 0.046 DBMET03129 0.132 0.069 DBMET03131 0.117 0.087 DBMET03132 0.121 0.081 DBMET03133 | DBMET03129 | |
| 0.12 | 0.028 | 0.159 | 5 Hydroxytryptamine agonist | 0.104 0.032 DBMET03128 0.133 0.025 DBMET03129 0.159 0.02 DBMET03130 0.095 0.035 DBMET03133 | DBMET03130 | |
| 0.094 | 0.005 | 0.103 | 5 Hydroxytryptamine 3B antagonist | 0.079 0.007 DBMET03128 0.067 0.009 DBMET03129 0.103 0.005 DBMET03130 0.035 0.026 DBMET03133 | DBMET03130 | |
| 0.095 | 0.007 | 0.095 | Dopamine D3 agonist | 0.075 0.01 DBMET03128 0.071 0.011 DBMET03129 0.058 0.015 DBMET03130 0.06 0.014 DBMET03133 | ||
| 0.2 | 0.112 | 0.581 | Hypoglycemic | 0.172 0.145 DBMET03128 0.205 0.107 DBMET03129 0.581 0.009 DBMET03131 0.581 0.009 DBMET03132 | DBMET03132 | |
| 0.096 | 0.009 | 0.161 | NMDA receptor subunit 3A antagonist | 0.05 0.02 DBMET03128 0.046 0.021 DBMET03129 0.048 0.021 DBMET03130 0.161 0.005 DBMET03133 | DBMET03133 | |
| 0.18 | 0.093 | 0.18 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.177 0.097 DBMET03128 0.176 0.098 DBMET03129 0.178 0.096 DBMET03130 0.16 0.127 DBMET03133 | ||
| 0.101 | 0.015 | 0.109 | 5 Hydroxytryptamine 6 antagonist | 0.1 0.015 DBMET03128 0.106 0.013 DBMET03129 0.109 0.012 DBMET03130 0.089 0.019 DBMET03133 | DBMET03130 | |
| 0.1 | 0.014 | 0.124 | 5 Hydroxytryptamine 2A agonist | 0.124 0.008 DBMET03128 0.115 0.01 DBMET03129 0.096 0.016 DBMET03130 0.111 0.011 DBMET03133 | DBMET03128 | |
| 0.093 | 0.009 | 0.101 | Nicotinic receptor alpha4 subunit antagonist | 0.078 0.014 DBMET03128 0.073 0.015 DBMET03129 0.096 0.009 DBMET03130 0.101 0.008 DBMET03133 | DBMET03133 | |
| 0.09 | 0.009 | 0.101 | 5 Hydroxytryptamine 4 antagonist | 0.099 0.007 DBMET03128 0.101 0.006 DBMET03129 0.079 0.013 DBMET03130 0.049 0.04 DBMET03133 | DBMET03129 | |
| 0.097 | 0.017 | 0.21 | NMDA 2C receptor antagonist | 0.073 0.03 DBMET03128 0.068 0.035 DBMET03129 0.078 0.026 DBMET03130 0.21 0.005 DBMET03133 | DBMET03133 | |
| 0.198 | 0.12 | 0.198 | Cardiotonic | 0.194 0.124 DBMET03128 0.197 0.122 DBMET03129 | ||
| 0.135 | 0.057 | 0.251 | Topoisomerase II inhibitor | 0.132 0.058 DBMET03128 0.115 0.071 DBMET03129 0.142 0.053 DBMET03130 0.251 0.024 DBMET03131 0.236 0.027 DBMET03132 0.226 0.028 DBMET03133 | DBMET03131 | |
| 0.1 | 0.023 | 0.147 | HIV-1 integrase (Strand Transfer) inhibitor | 0.059 0.043 DBMET03128 0.058 0.043 DBMET03129 0.055 0.045 DBMET03131 0.05 0.049 DBMET03132 0.147 0.013 DBMET03133 | DBMET03133 | |
| 0.143 | 0.066 | 0.143 | Neurotrophic factor | 0.126 0.085 DBMET03128 0.135 0.074 DBMET03129 0.115 0.103 DBMET03131 0.134 0.075 DBMET03132 | ||
| 0.121 | 0.044 | 0.141 | DOPA decarboxylase inhibitor | 0.141 0.026 DBMET03133 | DBMET03133 | |
| 0.108 | 0.032 | 0.115 | Acetylcholine nicotinic agonist | 0.079 0.058 DBMET03128 0.085 0.051 DBMET03129 0.115 0.028 DBMET03130 0.112 0.03 DBMET03133 | DBMET03130 | |
| 0.099 | 0.023 | 0.199 | Beta tubulin antagonist | 0.137 0.014 DBMET03128 0.199 0.008 DBMET03129 0.103 0.021 DBMET03130 0.164 0.01 DBMET03133 | DBMET03129 | |
| 0.081 | 0.006 | 0.081 | Opioid delta receptor agonist | 0.058 0.01 DBMET03128 0.053 0.012 DBMET03129 0.055 0.011 DBMET03130 0.036 0.024 DBMET03131 0.034 0.027 DBMET03132 0.05 0.013 DBMET03133 | ||
| 0.109 | 0.035 | 0.126 | Phosphodiesterase I inhibitor | 0.126 0.024 DBMET03128 0.111 0.033 DBMET03129 0.088 0.062 DBMET03130 | DBMET03128 | |
| 0.195 | 0.125 | 0.329 | Interleukin agonist | 0.291 0.052 DBMET03131 0.329 0.035 DBMET03132 0.234 0.091 DBMET03133 | DBMET03132 | |
| 0.143 | 0.075 | 0.183 | Adenylate cyclase stimulant | 0.126 0.11 DBMET03129 0.183 0.024 DBMET03133 | DBMET03133 | |
| 0.088 | 0.021 | 0.088 | Protein kinase C beta inhibitor | 0.082 0.027 DBMET03133 | ||
| 0.141 | 0.075 | 0.288 | Protein kinase stimulant | 0.137 0.078 DBMET03128 0.189 0.046 DBMET03129 0.129 0.084 DBMET03130 0.272 0.021 DBMET03131 0.288 0.018 DBMET03132 0.176 0.052 DBMET03133 | DBMET03132 | |
| 0.087 | 0.021 | 0.087 | Acetylcholine M5 receptor antagonist | 0.073 0.029 DBMET03128 0.07 0.031 DBMET03129 0.07 0.031 DBMET03130 | ||
| 0.081 | 0.017 | 0.081 | Dopamine transporter inhibitor | 0.068 0.021 DBMET03128 0.069 0.021 DBMET03129 0.073 0.019 DBMET03130 0.076 0.018 DBMET03133 | ||
| 0.08 | 0.02 | 0.093 | 5 Hydroxytryptamine 1A agonist | 0.075 0.021 DBMET03128 0.088 0.018 DBMET03129 0.093 0.017 DBMET03130 | DBMET03130 | |
| 0.148 | 0.088 | 0.148 | Heat shock protein 90 alpha antagonist | 0.137 0.101 DBMET03128 0.132 0.108 DBMET03129 0.138 0.1 DBMET03130 0.125 0.118 DBMET03133 | ||
| 0.097 | 0.039 | 0.139 | Adrenaline agonist | 0.139 0.018 DBMET03133 | DBMET03133 | |
| 0.142 | 0.083 | 0.146 | Heat shock protein 90 antagonist | 0.146 0.079 DBMET03128 0.138 0.088 DBMET03129 0.13 0.097 DBMET03133 | DBMET03128 | |
| 0.081 | 0.023 | 0.119 | Beta 3 adrenoreceptor antagonist | 0.073 0.03 DBMET03128 0.09 0.018 DBMET03129 0.119 0.01 DBMET03133 | DBMET03133 | |
| 0.092 | 0.034 | 0.092 | CC chemokine 5 receptor agonist | 0.081 0.061 DBMET03130 0.092 0.033 DBMET03133 | ||
| 0.071 | 0.014 | 0.131 | 5 Hydroxytryptamine 2C agonist | 0.063 0.019 DBMET03128 0.063 0.019 DBMET03129 0.076 0.012 DBMET03130 0.131 0.005 DBMET03133 | DBMET03133 | |
| 0.264 | 0.208 | 0.372 | 5 Hydroxytryptamine release inhibitor | 0.278 0.191 DBMET03128 0.31 0.155 DBMET03129 0.285 0.183 DBMET03130 0.371 0.098 DBMET03131 0.371 0.098 DBMET03132 0.372 0.097 DBMET03133 | DBMET03133 | |
| 0.141 | 0.085 | 0.289 | Diuretic | 0.12 0.104 DBMET03130 0.289 0.024 DBMET03131 0.269 0.028 DBMET03132 | DBMET03131 | |
| 0.115 | 0.06 | 0.132 | 5 Hydroxytryptamine 3A agonist | 0.132 0.046 DBMET03130 | DBMET03130 | |
| 0.191 | 0.136 | 0.357 | DNA synthesis inhibitor | 0.17 0.169 DBMET03128 0.184 0.147 DBMET03130 0.357 0.029 DBMET03131 0.326 0.036 DBMET03132 0.267 0.057 DBMET03133 | DBMET03131 | |
| 0.112 | 0.061 | 0.229 | Topoisomerase I inhibitor | 0.111 0.062 DBMET03128 0.11 0.062 DBMET03129 0.227 0.02 DBMET03131 0.229 0.02 DBMET03132 0.148 0.042 DBMET03133 | DBMET03132 | |
| 0.067 | 0.016 | 0.073 | Nicotinic receptor alpha3 subunit antagonist | 0.053 0.023 DBMET03128 0.063 0.018 DBMET03129 0.073 0.014 DBMET03130 0.057 0.021 DBMET03133 | DBMET03130 | |
| 0.074 | 0.027 | 0.115 | 5 Hydroxytryptamine 1 agonist | 0.063 0.031 DBMET03128 0.073 0.027 DBMET03129 0.115 0.018 DBMET03130 | DBMET03130 | |
| 0.086 | 0.039 | 0.102 | Histidine decarboxylase inhibitor | 0.102 0.031 DBMET03129 0.086 0.039 DBMET03133 | DBMET03129 | |
| 0.073 | 0.027 | 0.073 | Protein kinase C eta inhibitor | 0.052 0.042 DBMET03128 0.048 0.047 DBMET03131 0.063 0.032 DBMET03133 | ||
| 0.065 | 0.019 | 0.098 | Topoisomerase II beta inhibitor | 0.052 0.03 DBMET03128 0.056 0.026 DBMET03129 0.045 0.043 DBMET03130 0.046 0.04 DBMET03131 0.046 0.04 DBMET03132 0.098 0.009 DBMET03133 | DBMET03133 | |
| 0.136 | 0.092 | 0.149 | Heat shock protein 70 antagonist | 0.13 0.12 DBMET03128 0.136 0.09 DBMET03129 0.132 0.111 DBMET03130 0.136 0.092 DBMET03131 0.149 0.048 DBMET03132 | DBMET03132 | |
| 0.052 | 0.01 | 0.063 | Sigma 1 receptor antagonist | 0.048 0.011 DBMET03128 0.063 0.009 DBMET03129 0.044 0.011 DBMET03130 | DBMET03129 | |
| 0.087 | 0.047 | 0.088 | Estrogen-related receptor beta agonist | 0.088 0.045 DBMET03128 0.083 0.057 DBMET03129 0.08 0.067 DBMET03133 | DBMET03128 | |
| 0.113 | 0.072 | 0.113 | Interleukin 8 antagonist | 0.111 0.075 DBMET03133 | ||
| 0.058 | 0.019 | 0.086 | Factor III inhibitor | 0.06 0.018 DBMET03128 0.065 0.014 DBMET03129 0.064 0.014 DBMET03131 0.086 0.006 DBMET03132 0.064 0.014 DBMET03133 | DBMET03132 | |
| 0.053 | 0.014 | 0.053 | Nerve growth factor antagonist | 0.041 0.034 DBMET03129 0.044 0.028 DBMET03130 | ||
| 0.131 | 0.094 | 0.404 | Hemostatic | 0.121 0.111 DBMET03129 0.404 0.008 DBMET03131 0.391 0.008 DBMET03132 0.128 0.098 DBMET03133 | DBMET03131 | |
| 0.132 | 0.094 | 0.14 | Pregnane X receptor agonist | 0.14 0.073 DBMET03130 | DBMET03130 | |
| 0.082 | 0.044 | 0.095 | Acetylcholine M4 receptor antagonist | 0.081 0.045 DBMET03128 0.081 0.046 DBMET03129 0.095 0.032 DBMET03130 | DBMET03130 | |
| 0.072 | 0.035 | 0.094 | Beta adrenoreceptor antagonist | 0.07 0.038 DBMET03128 0.072 0.035 DBMET03129 0.094 0.019 DBMET03133 | DBMET03133 | |
| 0.045 | 0.007 | 0.053 | Nicotinic alpha3beta4 receptor agonist | 0.038 0.012 DBMET03128 0.038 0.012 DBMET03129 0.049 0.006 DBMET03130 0.053 0.005 DBMET03133 | DBMET03133 | |
| 0.066 | 0.029 | 0.083 | Beta 1 adrenoreceptor antagonist | 0.062 0.034 DBMET03128 0.061 0.034 DBMET03129 0.083 0.016 DBMET03133 | DBMET03133 | |
| 0.069 | 0.033 | 0.069 | Acetylcholine M3 receptor antagonist | 0.058 0.044 DBMET03128 0.058 0.044 DBMET03129 | ||
| 0.039 | 0.004 | 0.045 | NMDA receptor phencyclidine site antagonist | 0.037 0.004 DBMET03128 0.037 0.004 DBMET03129 0.029 0.005 DBMET03130 0.045 0.003 DBMET03133 | DBMET03133 | |
| 0.045 | 0.011 | 0.08 | Sigma 2 receptor antagonist | 0.063 0.007 DBMET03128 0.08 0.005 DBMET03129 0.04 0.013 DBMET03130 | DBMET03129 | |
| 0.077 | 0.043 | 0.085 | Glycine receptor agonist | 0.075 0.046 DBMET03128 0.075 0.046 DBMET03129 0.072 0.051 DBMET03131 0.072 0.051 DBMET03132 0.085 0.033 DBMET03133 | DBMET03133 | |
| 0.063 | 0.029 | 0.152 | Alpha tubulin antagonist | 0.086 0.018 DBMET03128 0.152 0.009 DBMET03129 0.15 0.009 DBMET03133 | DBMET03129 | |
| 0.144 | 0.111 | 0.298 | DNA methyltransferase I inhibitor | 0.185 0.077 DBMET03128 0.134 0.124 DBMET03129 0.298 0.027 DBMET03131 0.24 0.051 DBMET03132 | DBMET03131 | |
| 0.04 | 0.008 | 0.044 | 5 Hydroxytryptamine 6 agonist | 0.031 0.015 DBMET03128 0.031 0.015 DBMET03129 0.044 0.006 DBMET03130 0.028 0.022 DBMET03133 | DBMET03130 | |
| 0.058 | 0.026 | 0.1 | Glucose-6-phosphate translocase inhibitor | 0.06 0.024 DBMET03128 0.058 0.026 DBMET03129 0.1 0.006 DBMET03131 0.099 0.006 DBMET03132 0.052 0.034 DBMET03133 | DBMET03131 | |
| 0.144 | 0.112 | 0.197 | Amyloid beta aggregation inhibitor | 0.14 0.116 DBMET03128 0.197 0.079 DBMET03129 0.135 0.121 DBMET03133 | DBMET03129 | |
| 0.065 | 0.034 | 0.065 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.056 0.053 DBMET03129 0.062 0.04 DBMET03133 | ||
| 0.084 | 0.054 | 0.088 | Histamine H1 receptor antagonist | 0.088 0.05 DBMET03130 | DBMET03130 | |
| 0.057 | 0.027 | 0.08 | Beta 2 adrenoreceptor antagonist | 0.047 0.041 DBMET03128 0.051 0.035 DBMET03129 0.08 0.012 DBMET03133 | DBMET03133 | |
| 0.068 | 0.038 | 0.068 | Acetylcholine M2 receptor antagonist | 0.062 0.043 DBMET03128 0.063 0.042 DBMET03129 0.059 0.046 DBMET03130 | ||
| 0.113 | 0.085 | 0.186 | Alpha-N-acetylglucosaminidase inhibitor | 0.186 0.038 DBMET03131 0.186 0.038 DBMET03132 0.158 0.051 DBMET03133 | DBMET03132 | |
| 0.05 | 0.023 | 0.129 | Poly(ADP-ribose) polymerase inhibitor | 0.055 0.019 DBMET03130 0.129 0.005 DBMET03133 | DBMET03133 | |
| 0.036 | 0.01 | 0.036 | Dopamine autoreceptor agonist | 0.032 0.012 DBMET03128 0.028 0.014 DBMET03129 0.035 0.011 DBMET03130 | ||
| 0.081 | 0.055 | 0.135 | Glycine receptor antagonist | 0.078 0.059 DBMET03129 0.076 0.064 DBMET03130 0.135 0.011 DBMET03131 0.12 0.018 DBMET03132 0.087 0.046 DBMET03133 | DBMET03131 | |
| 0.093 | 0.068 | 0.136 | Phosphodiesterase 6D inhibitor | 0.136 0.015 DBMET03131 0.136 0.014 DBMET03132 | DBMET03132 | |
| 0.062 | 0.037 | 0.063 | Phosphodiesterase 1A inhibitor | 0.06 0.042 DBMET03128 0.062 0.036 DBMET03129 0.063 0.034 DBMET03130 | DBMET03130 | |
| 0.073 | 0.049 | 0.151 | NMDA 2 receptor antagonist | 0.151 0.016 DBMET03133 | DBMET03133 | |
| 0.062 | 0.038 | 0.066 | Androgen agonist | 0.066 0.034 DBMET03133 | DBMET03133 | |
| 0.061 | 0.038 | 0.066 | Heat shock protein 90 beta antagonist | 0.056 0.047 DBMET03128 0.066 0.032 DBMET03133 | DBMET03133 | |
| 0.044 | 0.021 | 0.068 | Phenylethanolamine N methyltransferase inhibitor | 0.038 0.033 DBMET03129 0.04 0.03 DBMET03130 0.068 0.005 DBMET03133 | DBMET03133 | |
| 0.043 | 0.02 | 0.048 | Nicotinic receptor beta4 subunit antagonist | 0.035 0.028 DBMET03128 0.035 0.028 DBMET03129 0.042 0.021 DBMET03130 0.048 0.017 DBMET03133 | DBMET03133 | |
| 0.165 | 0.143 | 0.458 | Immunostimulant | 0.458 0.035 DBMET03131 0.454 0.036 DBMET03132 0.153 0.152 DBMET03133 | DBMET03131 | |
| 0.061 | 0.039 | 0.061 | Bcl-xL inhibitor | 0.057 0.049 DBMET03129 0.057 0.051 DBMET03133 | ||
| 0.202 | 0.18 | 0.361 | Vasodilator, coronary | 0.249 0.135 DBMET03128 0.231 0.153 DBMET03129 0.193 0.189 DBMET03130 0.361 0.05 DBMET03131 0.357 0.052 DBMET03132 0.194 0.188 DBMET03133 | DBMET03131 | |
| 0.044 | 0.023 | 0.044 | Acid-sensing ion channel blocker | 0.04 0.028 DBMET03128 0.043 0.024 DBMET03129 0.04 0.029 DBMET03130 | ||
| 0.054 | 0.033 | 0.059 | Estrogen agonist | 0.059 0.03 DBMET03131 0.053 0.034 DBMET03132 | DBMET03131 | |
| 0.083 | 0.062 | 0.095 | mTOR complex 2 inhibitor | 0.08 0.068 DBMET03128 0.095 0.039 DBMET03129 0.082 0.063 DBMET03133 | DBMET03129 | |
| 0.088 | 0.07 | 0.108 | Protein kinase C mu inhibitor | 0.108 0.05 DBMET03133 | DBMET03133 | |
| 0.134 | 0.116 | 0.135 | Antipruritic | 0.135 0.114 DBMET03129 | DBMET03129 | |
| 0.071 | 0.054 | 0.078 | Glutamate decarboxylase inhibitor | 0.078 0.046 DBMET03133 | DBMET03133 | |
| 0.041 | 0.024 | 0.053 | 5 Hydroxytryptamine 2B agonist | 0.043 0.02 DBMET03128 0.041 0.024 DBMET03129 0.046 0.017 DBMET03130 0.053 0.011 DBMET03133 | DBMET03133 | |
| 0.037 | 0.023 | 0.037 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.055 | 0.041 | 0.087 | 5 Hydroxytryptamine 3 antagonist | 0.087 0.021 DBMET03130 | DBMET03130 | |
| 0.039 | 0.025 | 0.095 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.044 0.02 DBMET03130 0.095 0.007 DBMET03133 | DBMET03133 | |
| 0.043 | 0.031 | 0.112 | NMDA receptor subunit 3B antagonist | 0.112 0.009 DBMET03133 | DBMET03133 | |
| 0.042 | 0.031 | 0.052 | Guanylate cyclase inhibitor | 0.041 0.032 DBMET03128 0.041 0.032 DBMET03129 0.04 0.033 DBMET03130 0.052 0.019 DBMET03131 0.052 0.019 DBMET03132 | DBMET03132 | |
| 0.088 | 0.077 | 0.134 | Bronchodilator | 0.134 0.038 DBMET03128 0.11 0.053 DBMET03129 | DBMET03128 | |
| 0.086 | 0.075 | 0.086 | MAO A inhibitor | 0.082 0.078 DBMET03133 | ||
| 0.1 | 0.09 | 0.125 | Microtubule formation inhibitor | 0.108 0.077 DBMET03128 0.118 0.063 DBMET03129 0.11 0.073 DBMET03130 0.118 0.063 DBMET03131 0.125 0.055 DBMET03132 0.115 0.066 DBMET03133 | DBMET03132 | |
| 0.089 | 0.079 | 0.092 | Anabolic | 0.092 0.075 DBMET03133 | DBMET03133 | |
| 0.029 | 0.019 | 0.034 | Nicotinic alpha4beta2 receptor agonist | 0.034 0.013 DBMET03130 0.027 0.022 DBMET03133 | DBMET03130 | |
| 0.141 | 0.131 | 0.165 | Succinate dehydrogenase inhibitor | 0.165 0.087 DBMET03133 | DBMET03133 | |
| 0.078 | 0.069 | 0.105 | Acetylcholine agonist | 0.105 0.043 DBMET03130 | DBMET03130 | |
| 0.092 | 0.083 | 0.15 | DNA intercalator | 0.095 0.079 DBMET03128 0.091 0.085 DBMET03130 0.15 0.042 DBMET03131 0.135 0.05 DBMET03132 | DBMET03131 | |
| 0.033 | 0.024 | 0.033 | Estrogen receptor alpha agonist | 0.031 0.025 DBMET03133 | ||
| 0.039 | 0.032 | 0.039 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.032 | 0.025 | 0.032 | Catechol O-methyltransferase inhibitor | 0.03 0.028 DBMET03133 | ||
| 0.046 | 0.039 | 0.046 | Dopamine beta hydroxylase inhibitor | 0.046 0.04 DBMET03133 | ||
| 0.086 | 0.079 | 0.171 | Xanthine oxidase inhibitor | 0.171 0.027 DBMET03131 0.136 0.04 DBMET03132 | DBMET03131 | |
| 0.068 | 0.063 | 0.073 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.073 0.058 DBMET03128 0.073 0.058 DBMET03129 | DBMET03129 | |
| 0.061 | 0.056 | 0.103 | Phenylalanine 4-hydroxylase inhibitor | 0.103 0.024 DBMET03133 | DBMET03133 | |
| 0.098 | 0.093 | 0.123 | Acetylcholine release stimulant | 0.119 0.051 DBMET03128 0.123 0.044 DBMET03129 0.117 0.052 DBMET03130 | DBMET03129 | |
| 0.143 | 0.138 | 0.153 | Anticonvulsant | 0.153 0.125 DBMET03130 | DBMET03130 | |
| 0.064 | 0.06 | 0.1 | Telomerase inhibitor | 0.1 0.033 DBMET03130 | DBMET03130 | |
| 0.035 | 0.032 | 0.045 | Alpha 1d adrenoreceptor agonist | 0.045 0.021 DBMET03133 | DBMET03133 | |
| 0.027 | 0.024 | 0.027 | Estrogen-related receptor gamma antagonist | |||
| 0.058 | 0.055 | 0.059 | Phosphodiesterase 1C inhibitor | 0.059 0.052 DBMET03128 | DBMET03128 | |
| 0.099 | 0.097 | 0.359 | Amylase inhibitor | 0.1 0.097 DBMET03129 0.359 0.012 DBMET03131 0.291 0.019 DBMET03132 0.217 0.039 DBMET03133 | DBMET03131 | |
| 0.023 | 0.021 | 0.03 | 5 Hydroxytryptamine 1F agonist | 0.03 0.013 DBMET03130 | DBMET03130 | |
| 0.111 | 0.11 | 0.116 | Nav1.6 sodium channel blocker | 0.116 0.102 DBMET03128 0.113 0.107 DBMET03130 | DBMET03128 | |
| 0.192 | 0.191 | 0.399 | Apoptosis antagonist | 0.216 0.161 DBMET03129 0.399 0.039 DBMET03131 0.396 0.04 DBMET03132 | DBMET03131 | |
| 0.122 | 0.123 | 0.162 | GABA C receptor rho-2 antagonist | 0.128 0.109 DBMET03128 0.13 0.105 DBMET03130 0.162 0.059 DBMET03133 | DBMET03133 | |
| 0.047 | 0.049 | 0.064 | Nicotinic neuronal receptor agonist | 0.064 0.032 DBMET03130 0.05 0.045 DBMET03133 | DBMET03130 | |
| 0.014 | 0.017 | 0.017 | Nicotinic alpha4 receptor agonist | 0.017 0.011 DBMET03130 0.015 0.014 DBMET03133 | DBMET03130 | |
| 0.137 | 0.14 | 0.152 | Catenin beta inhibitor | 0.147 0.114 DBMET03128 0.152 0.101 DBMET03133 | DBMET03133 | |
| 0.129 | 0.133 | 0.369 | Platelet adhesion inhibitor | 0.131 0.13 DBMET03128 0.133 0.128 DBMET03129 0.369 0.015 DBMET03131 0.369 0.016 DBMET03132 | DBMET03132 | |
| 0.089 | 0.094 | 0.112 | Chelator | 0.112 0.062 DBMET03130 | DBMET03130 | |
| 0.083 | 0.09 | 0.208 | GABA C receptor agonist | 0.208 0.019 DBMET03133 | DBMET03133 | |
| 0.059 | 0.067 | 0.078 | Glutamate (mGluR7) antagonist | 0.067 0.048 DBMET03128 0.067 0.048 DBMET03129 0.078 0.03 DBMET03130 | DBMET03130 | |
| 0.078 | 0.086 | 0.13 | Butyrylcholinesterase inhibitor | 0.089 0.072 DBMET03128 0.13 0.042 DBMET03129 0.111 0.053 DBMET03130 | DBMET03129 | |
| 0.17 | 0.177 | 0.196 | Lipoxygenase inhibitor | 0.178 0.165 DBMET03129 0.196 0.145 DBMET03133 | DBMET03133 | |
| 0.134 | 0.142 | 0.364 | Non-steroidal antiinflammatory agent | 0.15 0.115 DBMET03128 0.364 0.018 DBMET03131 0.254 0.041 DBMET03132 | DBMET03131 | |
| 0.042 | 0.053 | 0.046 | Phosphodiesterase 6C inhibitor | 0.046 0.034 DBMET03130 | DBMET03130 | |
| 0.037 | 0.049 | 0.05 | Potassium channel small-conductance Ca-activated blocker | 0.047 0.028 DBMET03128 0.05 0.025 DBMET03129 0.044 0.033 DBMET03130 | DBMET03129 | |
| 0.037 | 0.05 | 0.046 | Histamine H1 receptor agonist | 0.046 0.025 DBMET03130 | DBMET03130 | |
| 0.052 | 0.065 | 0.101 | CDC25B inhibitor | 0.101 0.015 DBMET03130 0.063 0.046 DBMET03133 | DBMET03130 | |
| 0.1 | 0.113 | 0.187 | Toll-Like receptor 9 antagonist | 0.127 0.079 DBMET03128 0.135 0.073 DBMET03129 0.187 0.042 DBMET03130 | DBMET03130 | |
| 0.036 | 0.051 | 0.083 | NMDA 2A receptor antagonist | 0.083 0.019 DBMET03133 | DBMET03133 | |
| 0.059 | 0.074 | 0.197 | Antineoplastic antibiotic | 0.197 0.022 DBMET03131 0.19 0.023 DBMET03132 0.078 0.059 DBMET03133 | DBMET03131 | |
| 0.048 | 0.064 | 0.062 | Phosphodiesterase 1B inhibitor | 0.062 0.039 DBMET03128 0.061 0.041 DBMET03129 | DBMET03128 | |
| 0.086 | 0.104 | 0.153 | GABA C receptor antagonist | 0.153 0.028 DBMET03133 | DBMET03133 | |
| 0.08 | 0.098 | 0.131 | GABA C receptor rho-1 antagonist | 0.131 0.031 DBMET03133 | DBMET03133 | |
| 0.112 | 0.132 | 0.141 | MAP3K9 inhibitor | 0.122 0.111 DBMET03128 0.141 0.074 DBMET03133 | DBMET03133 | |
| 0.061 | 0.082 | 0.071 | GABA aminotransferase inhibitor | 0.071 0.059 DBMET03133 | DBMET03133 | |
| 0.016 | 0.041 | 0.031 | 5 Hydroxytryptamine 1D agonist | 0.031 0.018 DBMET03130 | DBMET03130 | |
| 0.034 | 0.059 | 0.047 | GABA B receptor antagonist | 0.047 0.023 DBMET03133 | DBMET03133 | |
| 0.039 | 0.065 | 0.053 | Nicotinic alpha7 receptor agonist | 0.053 0.039 DBMET03130 | DBMET03130 | |
| 0.174 | 0.201 | 0.234 | Insulysin inhibitor | 0.234 0.112 DBMET03133 | DBMET03133 | |
| 0.054 | 0.086 | 0.134 | Topoisomerase II alpha inhibitor | 0.076 0.056 DBMET03130 0.134 0.026 DBMET03131 0.125 0.028 DBMET03132 0.069 0.063 DBMET03133 | DBMET03131 | |
| 0.058 | 0.09 | 0.117 | Calcium antagonist | 0.117 0.037 DBMET03128 0.115 0.038 DBMET03129 0.096 0.051 DBMET03130 | DBMET03128 | |
| 0.074 | 0.107 | 0.087 | Carbonic anhydrase III inhibitor | 0.087 0.079 DBMET03133 | DBMET03133 | |
| 0.05 | 0.083 | 0.06 | Ryanodine receptor antagonist | 0.057 0.046 DBMET03128 0.06 0.038 DBMET03129 | DBMET03129 | |
| 0.014 | 0.05 | 0.041 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.041 0.012 DBMET03133 | DBMET03133 | |
| 0.059 | 0.095 | 0.077 | Androgen antagonist | 0.077 0.069 DBMET03133 | DBMET03133 | |
| 0.214 | 0.251 | 0.385 | Calcium channel L-type activator | 0.24 0.217 DBMET03128 0.24 0.217 DBMET03129 0.385 0.091 DBMET03133 | DBMET03133 | |
| 0.069 | 0.107 | 0.099 | Sphingomyelinase inhibitor | 0.099 0.061 DBMET03128 | DBMET03128 | |
| 0.012 | 0.054 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.007 DBMET03131 0.023 0.007 DBMET03132 | DBMET03132 | |
| 0.065 | 0.106 | 0.09 | Phosphodiesterase 11A inhibitor | 0.087 0.047 DBMET03128 0.09 0.043 DBMET03129 0.078 0.064 DBMET03130 | DBMET03129 | |
| 0.065 | 0.106 | 0.09 | Phosphodiesterase XI inhibitor | 0.087 0.047 DBMET03128 0.09 0.043 DBMET03129 0.078 0.064 DBMET03130 | DBMET03129 | |
| 0.065 | 0.108 | 0.078 | MAP kinase kinase 7 inhibitor | 0.078 0.052 DBMET03133 | DBMET03133 | |
| 0.112 | 0.156 | 0.202 | Interferon gamma antagonist | 0.202 0.04 DBMET03131 0.169 0.058 DBMET03132 0.129 0.112 DBMET03133 | DBMET03131 | |
| 0.064 | 0.111 | 0.083 | Antihistaminic | 0.083 0.073 DBMET03130 | DBMET03130 | |
| 0.086 | 0.133 | 0.134 | Toll-Like receptor 2 antagonist | 0.134 0.065 DBMET03133 | DBMET03133 | |
| 0.036 | 0.083 | 0.074 | Alpha-mannosidase inhibitor | 0.074 0.014 DBMET03131 0.074 0.014 DBMET03132 0.055 0.034 DBMET03133 | DBMET03132 | |
| 0.092 | 0.14 | 0.177 | Peroxidase inhibitor | 0.177 0.066 DBMET03133 | DBMET03133 | |
| 0.096 | 0.146 | 0.245 | Cell wall synthesis inhibitor | 0.228 0.021 DBMET03131 0.245 0.017 DBMET03132 0.171 0.047 DBMET03133 | DBMET03132 | |
| 0.032 | 0.082 | 0.048 | Acetylcholine muscarinic agonist | 0.048 0.046 DBMET03130 | DBMET03130 | |
| 0.153 | 0.205 | 0.173 | 5 Hydroxytryptamine 3E antagonist | 0.173 0.124 DBMET03130 | DBMET03130 | |
| 0.037 | 0.093 | 0.089 | Acetylcholine M5 receptor agonist | 0.089 0.027 DBMET03130 | DBMET03130 | |
| 0.176 | 0.235 | 0.386 | Interleukin 2 agonist | 0.386 0.032 DBMET03131 0.386 0.032 DBMET03132 | DBMET03132 | |
| 0.076 | 0.135 | 0.16 | Glutamate receptor antagonist | 0.16 0.045 DBMET03133 | DBMET03133 | |
| 0.08 | 0.143 | 0.121 | Electron transport complex I inhibitor | 0.121 0.046 DBMET03128 0.108 0.066 DBMET03129 0.11 0.063 DBMET03130 | DBMET03128 | |
| 0.065 | 0.133 | 0.086 | Granulocyte macrophage colony stimulating factor agonist | 0.086 0.061 DBMET03133 | DBMET03133 | |
| 0.041 | 0.11 | 0.082 | Na+ K+ transporting ATPase inhibitor | 0.082 0.048 DBMET03131 0.08 0.051 DBMET03132 | DBMET03131 | |
| 0.023 | 0.096 | 0.064 | Mannosidase inhibitor | 0.064 0.014 DBMET03131 0.064 0.014 DBMET03132 0.042 0.036 DBMET03133 | DBMET03132 | |
| 0.012 | 0.088 | 0.044 | Protein 30S ribosomal subunit inhibitor | 0.044 0.009 DBMET03131 0.042 0.009 DBMET03132 | DBMET03131 | |
| 0.071 | 0.147 | 0.115 | Multidrug resistance-associated protein 1 inhibitor | 0.093 0.091 DBMET03128 0.1 0.078 DBMET03129 0.112 0.058 DBMET03130 0.102 0.074 DBMET03131 0.115 0.055 DBMET03132 | DBMET03132 | |
| 0.022 | 0.099 | 0.055 | Aldose reductase inhibitor | 0.055 0.035 DBMET03131 | DBMET03131 | |
| 0.008 | 0.086 | 0.039 | Arginase inhibitor | 0.039 0.023 DBMET03132 | DBMET03132 | |
| 0.059 | 0.139 | 0.102 | Uric acid excretion stimulant | 0.097 0.056 DBMET03131 0.102 0.051 DBMET03132 | DBMET03132 | |
| 0.091 | 0.172 | 0.166 | DNA repair enzyme inhibitor | 0.164 0.021 DBMET03131 0.166 0.02 DBMET03132 | DBMET03132 | |
| 0.105 | 0.187 | 0.167 | Interleukin 6 antagonist | 0.167 0.068 DBMET03131 0.151 0.088 DBMET03132 | DBMET03131 | |
| 0.05 | 0.132 | 0.065 | Calcium channel P-type blocker | 0.065 0.039 DBMET03128 | DBMET03128 | |
| 0.115 | 0.203 | 0.14 | Phospholipase C inhibitor | 0.14 0.129 DBMET03133 | DBMET03133 | |
| 0.139 | 0.228 | 0.362 | Peptidyltransferase inhibitor | 0.354 0.012 DBMET03131 0.362 0.01 DBMET03132 | DBMET03132 | |
| 0.101 | 0.191 | 0.157 | Sphingosine 1-phosphate receptor 5 antagonist | 0.157 0.051 DBMET03133 | DBMET03133 | |
| 0.143 | 0.234 | 0.348 | Cholesterol antagonist | 0.314 0.082 DBMET03131 0.348 0.065 DBMET03132 | DBMET03132 | |
| 0.072 | 0.169 | 0.109 | Photosensitizer | 0.109 0.073 DBMET03131 0.109 0.073 DBMET03132 | DBMET03132 | |
| 0.056 | 0.154 | 0.117 | ATPase (Vacuolar H+) inhibitor | 0.111 0.027 DBMET03131 0.117 0.022 DBMET03132 | DBMET03132 | |
| 0.097 | 0.197 | 0.162 | Melanin inhibitor | 0.142 0.093 DBMET03131 0.162 0.067 DBMET03132 | DBMET03132 | |
| 0.036 | 0.139 | 0.059 | Potassium channel (Ca-activated) blocker | 0.059 0.044 DBMET03129 | DBMET03129 | |
| 0.035 | 0.142 | 0.062 | Protein kinase C alpha inhibitor | 0.062 0.057 DBMET03133 | DBMET03133 | |
| 0.038 | 0.145 | 0.061 | Adenine nucleotide translocase inhibitor | 0.058 0.033 DBMET03131 0.061 0.027 DBMET03132 | DBMET03132 | |
| 0.069 | 0.177 | 0.215 | Cyclooxygenase 3 inhibitor | 0.196 0.02 DBMET03131 0.215 0.014 DBMET03132 | DBMET03132 | |
| 0.05 | 0.158 | 0.098 | Protein kinase C delta inhibitor | 0.098 0.054 DBMET03133 | DBMET03133 | |
| 0.022 | 0.133 | 0.091 | Protein 50S ribosomal subunit inhibitor | 0.091 0.015 DBMET03131 0.09 0.016 DBMET03132 | DBMET03131 | |
| 0.052 | 0.166 | 0.096 | Breast cancer-resistant protein inhibitor | 0.096 0.059 DBMET03128 0.096 0.059 DBMET03129 | DBMET03129 | |
| 0.052 | 0.172 | 0.115 | UDP-glucose 4-epimerase inhibitor | 0.115 0.047 DBMET03131 0.115 0.047 DBMET03132 | DBMET03132 | |
| 0.094 | 0.216 | 0.155 | Potassium channel (Voltage-sensitive) blocker | 0.155 0.133 DBMET03130 | DBMET03130 | |
| 0.02 | 0.144 | 0.047 | Neuraminidase (Influenza A) inhibitor | 0.047 0.028 DBMET03131 | DBMET03131 | |
| 0.051 | 0.179 | 0.084 | Triose-phosphate isomerase inhibitor | 0.084 0.069 DBMET03131 0.084 0.069 DBMET03132 | DBMET03132 | |
| 0.053 | 0.184 | 0.088 | NADH dehydrogenase inhibitor | 0.088 0.06 DBMET03131 0.088 0.06 DBMET03132 | DBMET03132 | |
| 0.104 | 0.237 | 0.141 | CC chemokine 6 receptor antagonist | 0.141 0.037 DBMET03131 0.141 0.037 DBMET03132 | DBMET03132 | |
| 0.053 | 0.191 | 0.119 | DNA polymerase I inhibitor | 0.119 0.069 DBMET03132 | DBMET03132 | |
| 0.041 | 0.186 | 0.098 | Inducible nitric-oxide synthase inhibitor | 0.098 0.039 DBMET03133 | DBMET03133 | |
| 0.05 | 0.196 | 0.103 | Nitric-oxide synthase inhibitor | 0.103 0.056 DBMET03133 | DBMET03133 | |
| 0.067 | 0.216 | 0.579 | Angiogenesis stimulant | 0.579 0.008 DBMET03131 0.567 0.008 DBMET03132 | DBMET03131 | |
| 0.077 | 0.227 | 0.179 | Hexokinase inhibitor | 0.13 0.104 DBMET03130 0.17 0.058 DBMET03131 0.179 0.05 DBMET03132 | DBMET03132 | |
| 0.019 | 0.172 | 0.066 | Antibiotic Aminoglycoside-like | 0.066 0.007 DBMET03131 0.066 0.007 DBMET03132 | DBMET03132 | |
| 0.02 | 0.188 | 0.303 | Selectin antagonist | 0.303 0.005 DBMET03131 0.301 0.005 DBMET03132 | DBMET03131 | |
| 0.133 | 0.302 | 0.219 | Antiobesity | 0.219 0.188 DBMET03131 | DBMET03131 | |
| 0.124 | 0.297 | 0.392 | Alpha-glucosidase inhibitor | 0.369 0.127 DBMET03131 0.392 0.119 DBMET03132 | DBMET03132 | |
| 0.053 | 0.227 | 0.274 | Thrombolytic | 0.274 0.028 DBMET03131 0.251 0.033 DBMET03132 0.116 0.115 DBMET03133 | DBMET03131 | |
| 0.039 | 0.216 | 0.121 | Mediator release inhibitor | 0.107 0.061 DBMET03131 0.121 0.047 DBMET03132 | DBMET03132 | |
| 0.03 | 0.208 | 0.106 | Monophenol monooxygenase inhibitor | 0.106 0.071 DBMET03131 0.091 0.083 DBMET03132 | DBMET03131 | |
| 0.126 | 0.306 | 0.175 | Nitric-oxide synthase stimulant | 0.175 0.14 DBMET03133 | DBMET03133 | |
| 0.015 | 0.2 | 0.052 | Plasminogen activator inhibitor | 0.052 0.046 DBMET03133 | DBMET03133 | |
| 0.081 | 0.267 | 0.273 | Platelet antagonist | 0.273 0.063 DBMET03131 0.246 0.074 DBMET03132 | DBMET03131 | |
| 0.02 | 0.213 | 0.057 | Myc inhibitor | 0.057 0.034 DBMET03133 | DBMET03133 | |
| 0.055 | 0.267 | 0.249 | T cell inhibitor | 0.249 0.006 DBMET03130 0.079 0.071 DBMET03131 | DBMET03130 | |
| 0.045 | 0.267 | 0.105 | Bone formation stimulant | 0.105 0.101 DBMET03133 | DBMET03133 | |
| 0.035 | 0.267 | 0.058 | Lipocortins synthesis agonist | 0.057 0.043 DBMET03131 0.058 0.041 DBMET03132 | DBMET03132 | |
| 0.039 | 0.28 | 0.113 | Beta glucuronidase inhibitor | 0.113 0.053 DBMET03131 0.1 0.069 DBMET03132 | DBMET03131 | |
| 0.017 | 0.283 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.056 DBMET03131 | DBMET03131 | |
| 0.017 | 0.336 | 0.043 | DNA gyrase subunit A inhibitor | 0.043 0.028 DBMET03133 | DBMET03133 | |
| 0.053 | 0.39 | 0.184 | Insulin secretagoues | 0.177 0.051 DBMET03131 0.184 0.045 DBMET03132 0.129 0.098 DBMET03133 | DBMET03132 | |
| 0.035 | 0.388 | 0.191 | Anticoagulant | 0.191 0.057 DBMET03131 0.166 0.068 DBMET03132 | DBMET03131 | |
| 0.028 | 0.409 | 0.086 | Thioredoxin inhibitor | 0.086 0.069 DBMET03132 | DBMET03132 | |
| 0.016 | 0.399 | 0.059 | Heparanase inhibitor | 0.059 0.024 DBMET03131 0.059 0.024 DBMET03132 | DBMET03132 | |
| 0.033 | 0.444 | 0.165 | Cell adhesion inhibitor | 0.165 0.038 DBMET03131 0.163 0.039 DBMET03132 | DBMET03131 | |
| 0.011 | 0.432 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.016 DBMET03131 0.028 0.016 DBMET03132 | DBMET03132 | |
| 0.087 | 0.514 | 0.636 | Cyclophilin D inhibitor | 0.636 0.022 DBMET03131 0.632 0.022 DBMET03132 | DBMET03131 | |
| 0.031 | 0.463 | 0.174 | Hypolipemic | 0.174 0.114 DBMET03131 0.155 0.132 DBMET03132 | DBMET03131 | |
| 0.028 | 0.626 | 0.104 | Transcription factor NF kappa B stimulant | 0.104 0.036 DBMET03131 0.098 0.041 DBMET03132 | DBMET03131 | |
| 0.036 | 0.671 | 0.268 | Immunomodulator | 0.268 0.101 DBMET03131 0.23 0.132 DBMET03132 | DBMET03131 | |
| 0.009 | 0.646 | 0.03 | Elastase 2B inhibitor | 0.03 0.023 DBMET03130 | DBMET03130 | |
| 0.009 | 0.646 | 0.03 | Elastase 3B inhibitor | 0.03 0.023 DBMET03130 | DBMET03130 | |
| 0.009 | 0.646 | 0.03 | Elastase 3A inhibitor | 0.03 0.023 DBMET03130 | DBMET03130 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |